GAM
Grandview Asset Management’s AbbVie ABBV Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.35M | Buy |
18,039
+104
| +0.6% | +$19.3K | 1.07% | 22 |
|
|
2025
Q1 | $3.76M | Buy |
17,935
+85
| +0.5% | +$17.8K | 1.43% | 15 |
|
|
2024
Q4 | $3.17M | Sell |
17,850
-197
| -1% | -$35K | 1.16% | 19 |
|
|
2024
Q3 | $3.56M | Sell |
18,047
-168
| -0.9% | -$33.2K | 2.04% | 11 |
|
|
2024
Q2 | $3.12M | Sell |
18,215
-335
| -2% | -$57.5K | 1.83% | 14 |
|
|
2024
Q1 | $3.38M | Sell |
18,550
-300
| -2% | -$54.6K | 1.53% | 15 |
|
|
2023
Q4 | $2.92M | Sell |
18,850
-769
| -4% | -$119K | 1.53% | 15 |
|
|
2023
Q3 | $2.92M | Sell |
19,619
-1,489
| -7% | -$222K | 1.68% | 12 |
|
|
2023
Q2 | $2.84M | Sell |
21,108
-1,864
| -8% | -$251K | 2.77% | 11 |
|
|
2023
Q1 | $3.66M | Sell |
22,972
-2,304
| -9% | -$367K | 2.15% | 9 |
|
|
2022
Q4 | $4.09M | Sell |
25,276
-1,173
| -4% | -$190K | 2.54% | 9 |
|
|
2022
Q3 | $3.55M | Sell |
26,449
-1,181
| -4% | -$159K | 2.26% | 10 |
|
|
2022
Q2 | $4.23M | Sell |
27,630
-863
| -3% | -$132K | 2.37% | 9 |
|
|
2022
Q1 | $4.62M | Sell |
28,493
-541
| -2% | -$87.7K | 1.95% | 10 |
|
|
2021
Q4 | $3.93M | Buy |
29,034
+536
| +2% | +$72.6K | 1.58% | 12 |
|
|
2021
Q3 | $3.07M | Sell |
28,498
-192
| -0.7% | -$20.7K | 3.16% | 10 |
|
|
2021
Q2 | $3.23M | Buy |
28,690
+2,703
| +10% | +$305K | 1.77% | 15 |
|
|
2021
Q1 | $2.81M | Sell |
25,987
-206
| -0.8% | -$22.3K | 1.5% | 15 |
|
|
2020
Q4 | $2.81M | Buy |
26,193
+395
| +2% | +$42.3K | 1.84% | 12 |
|
|
2020
Q3 | $2.26M | Sell |
25,798
-1,296
| -5% | -$114K | 1.83% | 15 |
|
|
2020
Q2 | $2.66M | Buy |
+27,094
| New | +$2.66M | 2.32% | 9 |
|